Giving kids with early puberty a certain medicine doesn't seem to change their blood sugar, cholesterol, thyroid levels, testosterone, or bone strength during treatment.
Strongly supported
Multiple high-quality studies back this claim.
Not medical advice. For informational purposes only. Always consult a healthcare professional.
Giving kids with early puberty a certain medicine doesn't seem to change their blood sugar, cholesterol, thyroid levels, testosterone, or bone strength during treatment.
See the technical phrasing
Treatment with gonadotropin-releasing hormone analog (GnRHa) in children with central precocious puberty is not associated with statistically significant changes in insulin sensitivity (HOMA-IR), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), testosterone (T), or bone mineral density (BMD) over the treatment period.
What the research says
Supports
1 study
Study: The effect of gonadotropin-releasing hormone analog treatment on the endocrine system in central precocious puberty patients: a meta-analysis
This study provides evidence supporting the claim.
Contradicts
0 studies
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies